文献速递淋巴瘤

外显子组和基因组测序揭示套细胞淋巴瘤的编码与非编码驱动因素

Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.
PubMed 文献 · Blood · 2020-01-01

本研究对51例外显子组和34例基因组进行大规模基因组分析,并在191例有临床随访的套细胞淋巴瘤肿瘤中重测序验证。确认TP53和NOTCH1突变的预后关联,发现HNRNPH1基因单外显子周围反复出现的非编码突变,导致HNRNPH1异构体失衡并与较差预后相关。

要点

  • 确认TP53和NOTCH1突变在套细胞淋巴瘤中的预后关联。
  • 发现HNRNPH1基因周围反复非编码突变导致异构体失衡和蛋白过表达。
  • HNRNPH1异常剪接与套细胞淋巴瘤较差预后相关。

核心结论

  • 套细胞淋巴瘤中存在反复非编码突变破坏HNRNPH1自调控反馈机制,导致mRNA加工异常。

研究设计与样本

  • 对51例外显子组和34例基因组进行大规模基因组分析,并结合既往发表的外显子组队列。
  • 在191例有临床随访数据的套细胞淋巴瘤肿瘤中重测序验证外显子组发现的基因。

主要发现

  • 确认了TP53和NOTCH1突变的预后关联。
  • 测序发现HNRNPH1基因单个外显子周围反复出现的非编码突变。
  • 在103例RNA-seq数据中,携带这些突变的肿瘤显示HNRNPH1异构体明显失衡。
  • HNRNPH1改变剪接与较差预后相关,免疫组化显示蛋白表达显著增加。
  • 这些反复非编码突变通过破坏自调控反馈机制使HNRNPH1蛋白表达失调。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mantle cell lymphoma (MCL) is an uncommon B-cell non-Hodgkin lymphoma (NHL) that is incurable with standard therapies. The genetic drivers of this cancer have not been firmly established, and the features that contribute to differences in clinical course remain limited. To extend our understanding of the biological pathways involved in this malignancy, we performed a large-scale genomic analysis of MCL using data from 51 exomes and 34 genomes alongside previously published exome cohorts. To confirm our findings, we resequenced the genes identified in the exome cohort in 191 MCL tumors, each having clinical follow-up data. We confirmed the prognostic association of TP53 and NOTCH1 mutations. Our sequencing revealed novel recurrent noncoding mutations surrounding a single exon of the HNRNPH1gene. In RNA-seq data from 103 of these cases, MCL tumors with these mutations had a distinct imbalance of HNRNPH1 isoforms. This altered splicing of HNRNPH1 was associated with inferior outcomes in MCL and showed a significant increase in protein expression by immunohistochemistry. We describe a functional role for these recurrent noncoding mutations in disrupting an autoregulatory feedback mechanism, thereby deregulating HNRNPH1 protein expression. Taken together, these data strongly imply a role for aberrant regulation of messenger RNA processing in MCL pathobiology.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Pararajalingam P, Coyle KM, Arthur SE, et al. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020. PMID: 32160292. doi:10.1182/blood.2019002385

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。